| Bioactivity | Asoprisnil (J867), a selective progesterone receptor modulator, exhibits mixed progesterone agonist and antagonist effects on various progesterone targeted tissues in animal and human[1]. | ||||||||||||
| Name | Asoprisnil | ||||||||||||
| CAS | 199396-76-4 | ||||||||||||
| Formula | C28H35NO4 | ||||||||||||
| Molar Mass | 449.58 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Stewart EA, et al. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials. Hum Reprod. 2019 Apr 1;34(4):623 [2]. Wu XL, et al. Postcoital administration of asoprisnil inhibited embryo implantation and disturbed ultrastructure of endometrium in implantation window in mice. J Huazhong Univ Sci Technolog Med Sci. 2013 Apr;33(2):277-283. |
Asoprisnil
CAS: 199396-76-4 F: C28H35NO4 W: 449.58
Asoprisnil (J867), a selective progesterone receptor modulator, exhibits mixed progesterone agonist and antagonist effec
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.